3 ms·
The article points out that different cancers respond differently. High-mutation cancers are the most likely to be effectively treated with drug combinations or
by xenadu02 8y ago
The article points out that different cancers respond differently. High-mutation cancers are the most likely to be effectively treated with drug combinations or by using dosing cycles to manage the cancer.
There’s usually a metabolic cost to maintaining any kind of drug resistance. When the drug isn’t present that cost confers no benefit.
As always, cancer isn’t one disease and there won’t be any single silver bullet. Just lots of different strategies, eventually selected by sequencing a specific tumor to determine the most effective one.
- cannonedhamster 8y agoYes different cancers respond differently, obviously there isn't a silver bullet, but what's being suggested is dangerous and possibly life threatening and doesn't take into account that a lot of people already limit their chemo because of cost reasons and then die early. There's a whole reason trials exist and that's to determine effective doses and overall survivability. If there was a benefit seen in trials of lower doses they would already use those doses. This is junk science at best that completely ignores a massive body of research that already exists.